Abdulqadir Nashwan is the Director of Nursing for Education and Practice Development at HMGH and is a Member of Hamad Medical Corporation (HMC) in Qatar. He received his bachelor’s degree in Nursing (BSN) in 2007 & a master’s degree in Nursing Oncology (MSN) in 2011 from the Hashemite University (HU) in Jordan. He has assumed different roles in nursing oncology, starting with working as a registered nurse, charge nurse, head nurse, nurse educator, and nurse research scientist. In 2015, he was appointed as a Senior Adjunct Instructor at the faculty of nursing at the University of Calgary in Qatar (UCQ). His current research interests include Research Utilization, Evidenced-Based Practice, Clinical Hematology, Medical Oncology, Nursing Informatics, and Cancer Immunotherapy. Mr. Nashwan has published more than 50 research articles in peer-reviewed journals such as Blood, BMJ, and Journal of Pediatric Oncology Nursing. In November 2015, he received Award of Merit for Placing HMC at the Cutting Edge of Cancer Research as a part of the Stars of Excellence Program introduced by HMC. In October 2016, Mr. Nashwan completed a Cancer Biology & Therapeutics (CBT) Program, provided by Harvard Medical School (HMS). Mr. Nashwan has been committed to mentoring and encouraging young clinical investigators throughout his career; he has formally supervised the training of more than a dozen MSc candidates and nursing fellows. His expertise is routinely sought in an advisory capacity both nationally and internationally; he has served as a member of health policy subgroup at ICN Nurse Practitioner/Advance Practice Nursing Network (APNN), also he has served a reviewer for several reputable journals (e.g., Journal of Applied Nursing Research, Asia-Pacific Journal of Oncology Nursing, and Medical Science Monitor) and as an editorial board member for several journals.
Research Interests of Dr, Abdulqadir J. Nashwan are Research Utilization, Evidenced-Based Practice, Clinical Hematology, Medical Oncology, Nursing Informatics, and Cancer Immunotherapy